Sphera Management Technology Funds’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
211,800
+56,850
+37% +$751K 1.08% 31
2026
Q1
$2.14M Buy
154,950
+74,950
+94% +$1.13M 1.2% 28
2025
Q4
$1.44M Sell
80,000
-90,000
-53% -$1.62M 0.49% 42
2025
Q3
$3.15M Buy
170,000
+100,000
+143% +$1.57M 0.99% 21
2025
Q2
$1.12M Buy
+70,000
New +$1.25M 0.56% 48
2025
Q1
Sell
-40,000
Closed -$881K 67
2024
Q4
$881K Buy
+40,000
New +$770K 0.51% 45

Other funds holding CLBT

Sphera Management Technology Funds's CLBT Position: Q2 2026 in Review

Sphera Management Technology Funds increased its Cellebrite (CLBT) stake by 37% in Q2 2026, buying an estimated $751K and bringing the position to 211,800 shares worth $3.09M. The position accounts for 1.08% of the portfolio, ranked #31.

Sphera Management Technology Funds first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.15M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Sphera Management Technology Funds held 211,800 shares of Cellebrite worth $3.09M as of Q2 2026.
  • Sphera Management Technology Funds bought 56,850 Cellebrite shares in Q2 2026, an estimated $751K.
  • Cellebrite made up 1.08% of Sphera Management Technology Funds's portfolio in Q2 2026, its #31 holding.
  • Sphera Management Technology Funds first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
  • Sphera Management Technology Funds's Cellebrite position peaked at $3.15M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Sphera Management Technology Funds's 13F filing for Q2 2026, filed 14 Aug 2026.